Analyst
Deutsche Bank
Equibles does not estimate personal net worth.
James Glutskin is recorded as Analyst at Deutsche Bank. James Glutskin has spoken on 1 investor event across 1 company, most recently for HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY on April 23, 2026. The companies whose calls James Glutskin spoke on are classified in the Healthcare sector.
“Just a quick follow-up on the inflation story. I'm just wondering from a sort of inventory or a raw materials perspective, how many months do you guys sort of rebuy or forward buy, and how much are you sitting on?”
Deutsche Bank
Analyst
Transcript header (unverified)
HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY
Drug Manufacturers - Specialty & Generic · Healthcare
Trading update April 2026
HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY
